T. Seiler

Trajectories of Cardiac Function Following Treatment With an Impella Device in Patients With Acute Anterior ST-Elevation Myocardial Infarction

R. Kobza, M. Bossard, F. Cuculi, 2022, CJC open.

Metal free percutaneous coronary interventions in all-comers: First experience with a novel sirolimus-coated balloon

R. Kobza, M. Bossard, H. Garcia-Garcia, 2022, Cardiology journal.

Long-term outcomes after treatment of in-stent restenosis using the Absorb everolimus-eluting bioresorbable scaffold

R. Kobza, M. Bossard, F. Cuculi, 2021, Open Heart.

Treatment of in-stent restenosis using a dedicated super high-pressure balloon.

R. Kobza, M. Bossard, F. Cuculi, 2022, Cardiovascular revascularization medicine : including molecular interventions.

Direct Oral Anticoagulants Versus Vitamin K Antagonists for the Treatment of Left Ventricular Thrombi-Insights from a Swiss Multicenter Registry.

R. Kobza, M. Bossard, S. Stämpfli, 2023, The American journal of cardiology.

Manual compression versus MANTA device for access management after impella removal on the ICU

R. Kobza, M. Bossard, F. Cuculi, 2022, Scientific Reports.

Early Experience with the Biotronik Protego ICD Lead

R. Kobza, B. Berte, C. Grebmer, 2022, Journal of clinical medicine.

Recurrent implantable cardioverter-defibrillator shocks due to automatic deactivation of a right ventricular lead noise discrimination algorithm

R. Kobza, C. Grebmer, Thomas Seiler, 2022, HeartRhythm case reports.

Long-Term Outcomes After Implantation of Magnesium-Based Bioresorbable Scaffolds—Insights From an All-Comer Registry

R. Kobza, M. Bossard, G. Schüpfer, 2022, Frontiers in Cardiovascular Medicine.

Mitigating the risk of flow deterioration by deferring stent optimization in STEMI patients with large thrombus burden: Insights from a prospective cohort study

M. Bossard, F. Cuculi, A. Attinger-Toller, 2023, BMC Cardiovascular Disorders.